cilostazol has been researched along with h 89 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Inada, H; Onaya, T; Shindo, H; Tawata, M | 1 |
| Ito, H; Kimura, Y; Sudo, T | 1 |
| Fujita, T; Hattori, N; Miyamoto, N; Shimosawa, T; Tanaka, R; Urabe, T; Yatomi, Y | 1 |
| Hayashi, H; Sudo, T | 1 |
| Fisher, MJ; Liu, S; Paganini-Hill, A; Yang, F; Yu, C | 1 |
| Bajaj, M; Birnbaum, Y; Castillo, AC; Ling, S; Perez-Polo, JR; Qian, J; Ye, H; Ye, Y | 1 |
| Couraud, PO; Deli, MA; Horai, S; Morofuji, Y; Nakagawa, S; Niwa, M; Ozawa, M; Tanaka, K | 1 |
| Ge, Z; Li, Q; Sun, B; Xu, Z; Zuo, L | 1 |
| Jiang, H; Ren, D; Sui, S; Sun, C; Wang, B; Zhu, L | 1 |
10 other study(ies) available for cilostazol and h 89
| Article | Year |
|---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cilostazol, a cyclic AMP phosphodiesterase inhibitor, stimulates nitric oxide production and sodium potassium adenosine triphosphatase activity in SH-SY5Y human neuroblastoma cells.
Topics: Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dexamethasone; Humans; Inositol; Isoquinolines; Neuroblastoma; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphodiesterase Inhibitors; Sodium-Potassium-Exchanging ATPase; Sorbitol; Sulfonamides; Tetrazoles; Tumor Cells, Cultured | 1999 |
Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets.
Topics: Adenine; Adenylyl Cyclases; Blood Proteins; Cell Adhesion Molecules; Cilostazol; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Humans; Isoquinolines; Kinetics; Microfilament Proteins; Nitroprusside; Phosphodiesterase Inhibitors; Phosphoproteins; Phosphorylation; Platelet Aggregation Inhibitors; Sulfonamides; Tetrazoles | 2003 |
Protein kinase A-dependent suppression of reactive oxygen species in transient focal ischemia in adrenomedullin-deficient mice.
Topics: Adrenomedullin; Animals; Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Heterozygote; Immunoblotting; Immunohistochemistry; Ischemic Attack, Transient; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphodiesterase Inhibitors; Reactive Oxygen Species; Sulfonamides; Tetrazoles | 2009 |
Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3beta in platelets.
Topics: Animals; Binding Sites; Blood Platelets; Cilostazol; Colforsin; Collagen; Cyclic AMP; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; In Vitro Techniques; Isoquinolines; Phosphatidylinositol 3-Kinases; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinolones; Rats; Rats, Sprague-Dawley; Serine; Sulfonamides; Tetrazoles | 2009 |
Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties.
Topics: Actins; Brain; Capillary Permeability; Carbazoles; Cells, Cultured; Cilostazol; Claudin-5; Dipyridamole; Drug Interactions; Electric Impedance; Endothelial Cells; Histamine; Humans; Isoquinolines; Phosphodiesterase Inhibitors; Protein Kinase Inhibitors; Pyrroles; Rolipram; Sulfonamides; Tetrazoles | 2012 |
Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes.
Topics: Animals; Blood Glucose; Blotting, Western; Cholesterol; Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Activation; Exenatide; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Hypoglycemic Agents; Isoquinolines; Lipoxins; Male; Mice; Myocardial Infarction; Myocardium; Peptides; Phosphodiesterase 3 Inhibitors; Phosphorylation; Protein Kinase Inhibitors; PTEN Phosphohydrolase; Receptors, Glucagon; Signal Transduction; Sulfonamides; Tetrazoles; Triglycerides; Up-Regulation; Venoms | 2013 |
Cilostazol strengthens barrier integrity in brain endothelial cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Assay; Blood-Brain Barrier; Capillaries; Cell Line; Cilostazol; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclosporine; Endothelial Cells; Fluorescent Antibody Technique; Glucose; Humans; Isoquinolines; Oxygen; Rats; Rats, Wistar; RNA, Messenger; Sulfonamides; Tetrazoles; Tight Junctions | 2013 |
Cilostazol promotes mitochondrial biogenesis in human umbilical vein endothelial cells through activating the expression of PGC-1α.
Topics: Base Sequence; Cilostazol; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; DNA, Mitochondrial; Gene Knockdown Techniques; Heat-Shock Proteins; Human Umbilical Vein Endothelial Cells; Humans; Intermittent Claudication; Isoquinolines; Mitochondrial Turnover; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphodiesterase 3 Inhibitors; Protein Kinase Inhibitors; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Sulfonamides; Tetrazoles; Transcription Factors | 2013 |
Cilostazol induces mitochondrial fatty acid β-oxidation in C2C12 myotubes.
Topics: Animals; Cadherins; Carnitine O-Palmitoyltransferase; CD36 Antigens; Cell Line; Cilostazol; Cyclic AMP Response Element-Binding Protein; ERRalpha Estrogen-Related Receptor; Fatty Acids; Gene Expression; Gene Knockdown Techniques; Iron Regulatory Protein 1; Isoquinolines; Mitochondria; Muscle Fibers, Skeletal; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Protein Kinase Inhibitors; Receptors, Estrogen; RNA, Small Interfering; Sulfonamides; Tetrazoles; Transcription Factors; Triglycerides | 2014 |